U.S. Transportation Stock News

NasdaqGS:AEIS
NasdaqGS:AEISElectronic

Why Advanced Energy Industries (AEIS) Is Down 8.3% After Q1 Beat, Higher Guidance and Capital Moves - And What's Next

Advanced Energy Industries recently reported first-quarter 2026 results showing sales of US$511.0 million and diluted EPS from continuing operations of US$1.58, alongside confirming a US$0.10 quarterly dividend and updating second-quarter guidance. The company also completed a multi‑year share repurchase program, filed new shelf registrations for up to 3.0 million ESOP‑related shares, and signaled an active acquisition pipeline supported by what management describes as a strong balance...
NasdaqGS:LIVN
NasdaqGS:LIVNMedical Equipment

Assessing LivaNova (LIVN) Valuation After Strong Recent Share Price Momentum

LivaNova overview and recent share moves LivaNova (LIVN) has drawn investor attention after recent share price moves, with the stock showing double digit total returns over the past year, as well as solid gains over the past month and the past three months. See our latest analysis for LivaNova. The recent 7-day share price return of 18.01%, alongside a 16.96% year-to-date share price return and a 60.94% 1-year total shareholder return, indicates that momentum has been building over both...
NasdaqCM:AEHR
NasdaqCM:AEHRSemiconductor

A Look At Aehr Test Systems (AEHR) Valuation After Record US$41 Million AI Order And Backlog Surge

Aehr Test Systems (AEHR) is back on traders’ radars after securing a record US$41 million order from an existing hyperscale AI customer, along with a backlog that nearly doubled year over year. See our latest analysis for Aehr Test Systems. Despite a 5.65% one day share price pullback to US$91.26 as traders react to mixed earnings and recent equity issuance, Aehr’s 30 day share price return of 81.61% and very large 1 year total shareholder return suggest momentum is still firmly positive. If...
NasdaqGS:PODD
NasdaqGS:PODDMedical Equipment

Insulet (PODD) Is Down 6.8% After Raising 2026 Guidance And Advancing Closed‑Loop Trial - What's Changed

In early May 2026, Insulet Corporation reported that first‑quarter revenue rose to US$761.7 million with net income of US$91.1 million, while also raising its full‑year 2026 GAAP revenue growth guidance to 22%–24% and projecting second‑quarter GAAP revenue growth of 21%–23%. At the same time, Insulet began enrolling participants in its EVOLVE pivotal trial for a fully closed‑loop insulin delivery system for type 2 diabetes, signaling an effort to extend its technology beyond current users...
NasdaqGS:MRNA
NasdaqGS:MRNABiotechs

Moderna (MRNA) Is Up 5.7% After Strong Flu Data and Completed Buyback Program - What's Changed

In the first quarter of 2026, Moderna reported revenue of US$389 million versus US$108 million a year earlier, alongside a net loss of US$1.34 billion and basic loss per share of US$3.40, while also disclosing that it completed a US$1.34 billion share repurchase program launched in 2022. Alongside these results, Moderna’s publication of positive late-stage data for its mRNA-1010 flu vaccine and early-stage success in a hantavirus vaccine program underpins how its mRNA platform is being...
NasdaqGS:WDC
NasdaqGS:WDCTech

Western Digital Ends Sandisk Link To Sharpen Pure Play AI Storage Story

Western Digital has launched a share swap program allowing investors to exchange Sandisk stock for NasdaqGS:WDC shares. The company plans to exit all remaining Sandisk holdings, completing the unwind of its historic equity link after the Sandisk spinoff. This move simplifies Western Digital's capital structure and removes cross ownership between the two storage businesses. For investors watching NasdaqGS:WDC, this step comes after a period of very strong share price performance. The stock...
NYSE:GE
NYSE:GEAerospace & Defense

A Look At General Electric (GE) Valuation After Fresh Aerospace Deal And Robust First Quarter Earnings

Why GE stock is back in focus after fresh aerospace news General Electric (GE) is back on investor radar after reporting robust first quarter earnings, announcing a new F404 engine agreement with Turkish Aerospace Industries, and confirming that full year guidance remains intact despite higher costs. See our latest analysis for General Electric. GE’s latest aerospace deal and reaffirmed outlook come after a mixed stretch for the stock, with a 4.9% 1 month share price return and a 5.7% 3 month...
NasdaqGS:CRUS
NasdaqGS:CRUSSemiconductor

Cirrus Logic (CRUS) Valuation Check After Strong Recent Share Price Performance

Cirrus Logic stock overview after recent performance Cirrus Logic (CRUS) has attracted fresh attention after a strong run, with the stock up about 16% over the past month and 20% in the past 3 months, closing recently at US$171.68. For investors tracking longer horizons, Cirrus Logic’s total return stands at about 43% year to date and 76% over the past year, with 3 year and 5 year total returns of roughly 119% and 134% respectively. See our latest analysis for Cirrus Logic. At the...
NYSE:AWK
NYSE:AWKWater Utilities

Should American Water’s Q1 Earnings, Dividend Hike and Service Investments Require Action From AWK Investors?

In the past quarter, American Water Works Company, Inc. reported first-quarter 2026 sales of US$1,207 million, with net income of US$196 million and basic earnings per share from continuing operations of US$1, while also declaring a quarterly dividend of US$0.895 per share payable on June 2, 2026. Alongside these financial results, the company has been recognized for workplace culture and customer satisfaction and continued to invest in water quality, infrastructure, and community programs...
NYSE:LAZ
NYSE:LAZCapital Markets

Assessing Lazard (LAZ) Valuation After Mixed Q1 2026 Results Weigh On Investor Sentiment

What the mixed Q1 report means for Lazard (LAZ) stock Lazard (LAZ) reported mixed Q1 2026 results, with a strong revenue outcome but adjusted earnings per share below analyst expectations, a combination that helped drive a recent 7.8% drop in the stock. See our latest analysis for Lazard. Over the past year, Lazard’s total shareholder return of 11.2% contrasts with a 6.6% year to date share price decline and a 12.8% 1 month share price gain. This suggests momentum has recently cooled but not...
NasdaqGS:QS
NasdaqGS:QSAuto Components

QuantumScape Starts Eagle Line As Licensing Revenue Story Begins

QuantumScape (NasdaqGS:QS) has started operations at its Eagle Line pilot-scale solid-state battery production facility. The company has recorded its first billings from ecosystem partners, initiating its licensing and royalty revenue stream. These developments represent a shift from pure development work to initial commercialization and monetization of its battery technology. QuantumScape focuses on solid-state lithium-metal batteries aimed at electric vehicles and related applications, a...
NYSE:BIRK
NYSE:BIRKLuxury

Is It Time To Revisit Birkenstock Holding (BIRK) After Recent Share Price Pullback

If you are wondering whether Birkenstock Holding stock is attractively priced or still too expensive for your portfolio, this article breaks down what the current valuation implies. The stock last closed at US$39.04, with recent returns of 0.8% over 7 days, 12.6% over 30 days, and a 6.5% decline year to date, alongside a 25.6% decline over the last year. Recent coverage around Birkenstock Holding has focused on its position in the consumer durables space and how investors are weighing brand...
NasdaqGS:DYN
NasdaqGS:DYNBiotechs

A Look At Dyne Therapeutics (DYN) Valuation After New CNS Tauopathy Data And Pipeline Expansion Potential

Why Dyne’s latest CNS data matters for DYN stock Dyne Therapeutics (DYN) recently announced new preclinical data on its FORCE platform, showing MAPT RNA knockdown in the central nervous system. This places potential tauopathy applications alongside its existing neuromuscular focus. For you as an investor, this update is less about near term revenue and more about how Dyne’s technology might support a broader pipeline over time, including Alzheimer’s related programs. See our latest analysis...
NasdaqGS:AMPH
NasdaqGS:AMPHPharmaceuticals

Amphastar Pharmaceuticals (AMPH) Margin Compression Reinforces Bearish Narrative Despite Stable Revenue

Amphastar Pharmaceuticals (AMPH) closed out FY 2025 with fourth quarter revenue of US$183.1 million and basic EPS of US$0.53, compared with prior year Q4 revenue of US$186.5 million and EPS of US$0.79, as trailing net profit margin moved from 21.8% to 13.6% over the last 12 months. Over the past six reported quarters, revenue has remained within a relatively narrow range of roughly US$170 million to US$192 million per quarter, while EPS has ranged from US$0.37 to US$0.83, giving investors a...
NYSE:OKLO
NYSE:OKLOElectric Utilities

Did Accelerated NRC Approval of Aurora Design Criteria Just Shift Oklo's (OKLO) Investment Narrative?

In early May 2026, Oklo Inc. reported that the U.S. Nuclear Regulatory Commission approved its Principal Design Criteria topical report for the Aurora powerhouse in Idaho on an accelerated timeline, establishing the core safety, reliability and performance requirements that can be referenced in future licensing applications. This rapid approval materially reduces repetitive regulatory review for Oklo’s advanced reactors and signals that federal modernization efforts are beginning to...
NasdaqGS:CLBT
NasdaqGS:CLBTSoftware

Cellebrite FedRAMP Win Raises Questions On Undervalued Stock Weak Momentum

Cellebrite DI's Cellebrite Government Cloud platform has received FedRAMP High Authorization, the top federal cloud security standard. The U.S. Department of Justice acted as the sponsoring agency for this authorization. The approval covers handling of highly sensitive unclassified data for federal agencies. Cellebrite DI (NasdaqGS:CLBT) now has its Cellebrite Government Cloud cleared at the FedRAMP High level, placing it among a relatively small group of vendors that meet the federal...
NYSE:FTV
NYSE:FTVMachinery

Is It Too Late To Consider Fortive (FTV) After Its Recent Share Price Climb?

If you are wondering whether Fortive at around US$60.90 is still a fair deal or already pricing in the story, this breakdown will help you size up what you are really paying for the stock. Over the shorter term, Fortive has posted returns of 1.9% over the last week, 7.1% over the last month, 9.9% year to date and 16.3% over the past year, which raises questions about how much of the current valuation is already reflected in the recent share price. Recent attention on Fortive has centered on...
NYSE:AOS
NYSE:AOSBuilding

Will China-Driven Guidance Cut and Buyback History Change A. O. Smith's (AOS) Narrative

In late April 2026, A. O. Smith reported first-quarter 2026 results showing lower sales and earnings year over year, cut its full-year 2026 earnings and sales guidance due to ongoing weakness in China, and confirmed that it has repurchased 59.41 million shares for about US$3.06 billion since launching its buyback in 2007. At the same time, sentiment weakened as analysts reduced earnings estimates, A. O. Smith was added to the Zacks Rank #5 (Strong Sell) list, and a large institutional...
NYSE:BRC
NYSE:BRCCommercial Services

Is It Too Late To Consider Brady (BRC) After Recent Share Price Weakness?

For investors wondering if Brady's current share price still offers value or if most of the opportunity is already priced in, this article walks through what the numbers are really saying about the stock. Brady closed at US$79.53, with a 2.8% decline over the last 7 days and a 1.0% decline over 30 days, while still showing returns of 1.1% year to date and 9.9% over the last year. These price moves sit against a backdrop of ongoing investor interest in Commercial Services companies like Brady...
NasdaqGS:GFS
NasdaqGS:GFSSemiconductor

Is GLOBALFOUNDRIES (GFS) Too Expensive After Recent 97% One-Year Share Price Surge

GLOBALFOUNDRIES stock might already be on your radar, but if you are wondering whether the recent excitement is backed up by value or just momentum, this is where the valuation story starts to take shape. At a last close of US$70.93, the stock shows returns of 9.8% over 7 days, 61.5% over 30 days, 92.4% year to date and 97.4% over the past year. This raises fair questions about how much future upside or downside is already reflected in the price. Recent coverage has focused on GLOBALFOUNDRIES...
NasdaqGS:IMKT.A
NasdaqGS:IMKT.AConsumer Retailing

Ingles Markets (IMKT.A) Valuation After Earnings Jump And Activist Board Election

Ingles Markets (IMKT.A) is back in focus after reporting second quarter earnings that showed higher net income alongside relatively steady sales, as well as an activist driven board shake up that could influence future capital allocation. See our latest analysis for Ingles Markets. The share price has eased in the short term, with a 1 day share price return of 2.96% lower and a 7 day share price return of 6.22% lower. However, the year to date share price return of 23.12% and 1 year total...
NYSE:SQM
NYSE:SQMChemicals

A Look At Sociedad Química y Minera de Chile’s Valuation After Strong Recent Share Price Performance

How Sociedad Química y Minera de Chile Stock Has Been Performing Sociedad Química y Minera de Chile (NYSE:SQM) has drawn attention after its recent share performance, with the stock last closing at US$91.60 and posting a 31.4% year to date total return. Over the past month, SQM has returned 16.7%. The past 3 months show a 28.1% gain, and the past year reflects a very large 169.3% total return. This performance sets the stage for a closer look at fundamentals. See our latest analysis for...
NYSE:KWR
NYSE:KWRChemicals

A Look At Quaker Chemical (KWR) Valuation After Recent Share Price Momentum

Why Quaker Chemical (KWR) is Getting Fresh Attention Quaker Chemical (KWR) has caught fresh attention after recent share price moves, with the stock showing mixed returns over the past year, which prompts a closer look at its fundamentals and regional revenue mix. See our latest analysis for Quaker Chemical. The recent 16.88% 1 month share price return, on top of a 5.19% 7 day share price gain, contrasts with a 15.95% 3 month share price decline and mixed multi year total shareholder returns...
NYSE:INSW
NYSE:INSWOil and Gas

International Seaways (INSW) Valuation Check After Earnings Beat And Tanker Market Windfall

International Seaways (INSW) just posted first quarter results that sharply outpaced expectations, with revenue of US$325.48 million and net income of US$286.14 million, as tanker markets reacted to the closure of the Strait of Hormuz. See our latest analysis for International Seaways. That earnings surprise sits alongside very strong recent trading, with the share price at US$90.18 after a 22.41% 1 month share price return and 91.91% year to date share price return. The 1 year total...